Stablepharma has announced the appointment of Dr. Kenny Simmen as its Chief Business Officer, effective March 1, 2025. Following a year of service on the company’s Advisory Board, Dr. Simmen will now lead Stablepharma’s business development efforts, including partnering and licensing activities, as part of the company’s ambitious growth strategy. Dr Simmen has 30 years […]
Read More
London, 19th February 2025 – UK-based biotechnology firm Stablepharma Ltd has been awarded €2.5 million through the prestigious European Innovation Council (EIC) Accelerator program. The grant recognises the company’s cutting-edge fridge-free pharmaceutical technology, which meets EIC’s rigorous criteria for excellence, impact, and risk management. Stablepharma is among 71 companies from 16 countries across Europe selected […]
Read More